COVID-19 肺炎与肺血管：地狱里的婚姻。
COVID-19 pneumonia and the pulmonary vasculature: a marriage made in hell.
机构信息
The Interstitial Lung Disease Unit, Royal Brompton and Harefield Hospitals, London, UK
National Heart and Lung Institute, Imperial College London, London, UK.
出版信息
Eur Respir J. 2021 Sep 16;58(3). doi: 10.1183/13993003.00811-2021. Print 2021 Sep.
Abstract
摘要
[链接]
相似文献
1
COVID-19 pneumonia and the pulmonary vasculature: a marriage made in hell.COVID-19 肺炎与肺血管：地狱里的婚姻。
Eur Respir J. 2021 Sep 16;58(3). doi: 10.1183/13993003.00811-2021. Print 2021 Sep.
2
Pulmonary Vasculature: A Target for COVID-19.肺血管系统：新冠病毒病的一个靶点
Am J Respir Crit Care Med. 2021 Jan 15;203(2):260-261. doi: 10.1164/rccm.202009-3564LE.
3
Cardiovascular system in the sars-CoV-2: impact of therapies.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染中的心血管系统：治疗的影响
J Hypertens. 2021 Jul 1;39(7):1306-1308. doi: 10.1097/HJH.0000000000002860.
4
[Cardiovascular system and COVID-19].[心血管系统与新型冠状病毒肺炎]
Turk Kardiyol Dern Ars. 2020 Oct;48(7):635-639. doi: 10.5543/tkda.2020.65204.
5
Systemic endothelial dysfunction: A common pathway for COVID-19, cardiovascular and metabolic diseases.全身内皮功能障碍：新冠病毒病、心血管疾病和代谢性疾病的共同途径。
Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1401-1402. doi: 10.1016/j.numecd.2020.05.007. Epub 2020 May 18.
6
COVID-19: (mis)managing an announced Black Swan.新冠疫情：对已宣布的黑天鹅事件的（不当）应对
Eur Heart J. 2020 May 14;41(19):1779-1782. doi: 10.1093/eurheartj/ehaa435.
7
Statin therapy in COVID-19 infection.新冠病毒感染中的他汀类药物治疗。
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(4):258-259. doi: 10.1093/ehjcvp/pvaa042.
8
Statins in COVID-19: A new ray of hope.新冠疫情中的他汀类药物：一线新希望。
Heart Lung. 2020 Nov-Dec;49(6):887-889. doi: 10.1016/j.hrtlng.2020.07.012. Epub 2020 Aug 11.
9
Cardiovascular Imaging in COVID-19.新型冠状病毒肺炎中的心血管成像
Arq Bras Cardiol. 2021 Aug;117(2):415. doi: 10.36660/abc.20201356.
10
COVID-19 and Cardiovascular Health: This Is a Public Service Announcement.2019冠状病毒病与心血管健康：这是一则公益公告。
J Am Coll Cardiol. 2021 Jan 19;77(2):170-172. doi: 10.1016/j.jacc.2020.11.027.
引用本文的文献
1
Letter to the Editor: Pulmonary circulation abnormalities in post-acute COVID-19 syndrome and acute vascular distress syndrome.致编辑的信：新冠后急性综合征和急性血管窘迫综合征中的肺循环异常
Eur Radiol. 2024 Jun;34(6):4189-4190. doi: 10.1007/s00330-023-10349-0. Epub 2023 Nov 10.
2
Pulmonary circulation abnormalities in post-acute COVID-19 syndrome: dual-energy CT angiographic findings in 79 patients.急性 COVID-19 后综合征中的肺循环异常：79 例患者的双能 CT 血管造影结果。
Eur Radiol. 2023 Jul;33(7):4700-4712. doi: 10.1007/s00330-023-09618-9. Epub 2023 Apr 25.
3
Microvascular injuries, secondary edema, and inconsistencies in lung vascularization between affected and nonaffected pulmonary segments of non-critically ill hospitalized COVID-19 patients presenting with clinical deterioration.非危重症住院 COVID-19 患者在临床恶化时，其肺部受累和未受累节段之间的肺血管化存在差异，表现为微血管损伤、继发性水肿和不一致性。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221096040. doi: 10.1177/17534666221096040.
本文引用的文献
1
Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease.肺血容量分布改变作为预测 COVID-19 疾病结局的生物标志物。
Eur Respir J. 2021 Sep 16;58(3). doi: 10.1183/13993003.04133-2020. Print 2021 Sep.
2
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities.进行性纤维性间质性肺病：临床不确定性、共识建议和研究重点。
Lancet Respir Med. 2020 Sep;8(9):925-934. doi: 10.1016/S2213-2600(20)30355-6.
3
Functional respiratory imaging identifies redistribution of pulmonary blood flow in patients with COVID-19.功能性呼吸成像可识别新冠病毒肺炎患者肺血流的重新分布。
Thorax. 2021 Feb;76(2):182-184. doi: 10.1136/thoraxjnl-2020-215395. Epub 2020 Aug 28.
4
Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations.严重 COVID-19 中的肺血管病：生理学、影像学和血液学观察。
Am J Respir Crit Care Med. 2020 Sep 1;202(5):690-699. doi: 10.1164/rccm.202004-1412OC.
5
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
6
Idiopathic pulmonary fibrosis: airway volume measurement identifies progressive disease on computed tomography scans.特发性肺纤维化：气道容积测量可在计算机断层扫描上识别疾病进展情况。
ERJ Open Res. 2020 Feb 17;6(1). doi: 10.1183/23120541.00290-2019. eCollection 2020 Jan.
7
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.尼达尼布治疗进行性纤维化间质性肺疾病。
N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
8
Defining a pathological role for the vasculature in the development of fibrosis and pulmonary hypertension in interstitial lung disease.确定血管系统在间质性肺疾病的纤维化和肺动脉高压发展过程中的病理作用。
Am J Physiol Lung Cell Mol Physiol. 2019 Oct 1;317(4):L431-L433. doi: 10.1152/ajplung.00330.2019. Epub 2019 Aug 21.
9
Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis.应用 CT 分析自动化技术对特发性肺纤维化患者的结局进行纵向预测。
Eur Respir J. 2019 Sep 30;54(3). doi: 10.1183/13993003.02341-2018. Print 2019 Sep.
10
Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort study.深度学习在高分辨率 CT 上对肺纤维化疾病的分类：一项病例队列研究。
Lancet Respir Med. 2018 Nov;6(11):837-845. doi: 10.1016/S2213-2600(18)30286-8. Epub 2018 Sep 16.
Zotero 插件